CS logo
small CS logo
Institute of Hematology and Transfusion Medicine

Warsaw, Poland
Public medical center in Warsaw
Chocimska 5, 00-791 Warszawa

About Institute of Hematology and Transfusion Medicine


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Institute of Hematology and Transfusion Medicine


During the past decade, Institute of Hematology and Transfusion Medicine conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of FK463 for the Treatment of Invasive Aspergillosis
1999-01-29
2002-01-31
Completed
326
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
1999-02-27
2002-01-27
Completed
75

Rows per page:

1–24 of 24

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Institute of Hematology and Transfusion Medicine" #1 sponsor was "Baxalta now part of Shire" with 4 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Hematology and Transfusion Medicine" #1 collaborator was "Laboratoire français de Fractionnement et de Biotechnologies" with 1 trials as a collaborator, "Medical Research Agency, Poland" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBaxalta now part of Shire: 4Baxalta now part of Shire: 4AOP OrphanPharmaceuticals AG: 3AOP OrphanPharmaceuticals AG: 3Incyte Corporation: 3Incyte Corporation: 3Astellas Pharma Inc: 2Astellas Pharma Inc: 2Celgene: 2Celgene: 2Akinion Pharmaceuticals AB: 1Akinion Pharmaceuticals AB: 1Antisoma Research: 1Antisoma Research: 1Apellis Pharmaceuticals, Inc.: 1Apellis Pharmaceuticals, Inc.: 1Erasme University Hospital: 1Erasme University Hospital: 1Karyopharm Therapeutics Inc: 1Karyopharm Therapeutics Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsLaboratoire français deFractionnement et deBiotechnologies: 1Laboratoire français deFractionnement et deBiotechnologies: 1Medical ResearchAgency, Poland: 1Medical ResearchAgency, Poland: 1Medpace, Inc.: 1Medpace, Inc.: 1PharmaEssentia (Co-Sponsor for USA): 1PharmaEssentia (Co-Sponsor for USA): 1PharmaEssentiaCorporation (Co-Sponsor for USA): 1PharmaEssentiaCorporation (Co-Sponsor for USA): 1PharmaEssentiaCorporation (for theU.S.): 1PharmaEssentiaCorporation (for theU.S.): 1Theradex: 1Theradex: 1

Clinical Trials Conditions at Institute of Hematology and Transfusion Medicine


According to Clinical.Site data, the most researched conditions in "Institute of Hematology and Transfusion Medicine" are "Polycythemia Vera" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Hemophilia B" (2 trials), "Myelofibrosis" (2 trials) and "Post Essential Thrombocythemia Myelofibrosis" (2 trials). Many other conditions were trialed in "Institute of Hematology and Transfusion Medicine" in a lesser frequency.

Clinical Trials Intervention Types at Institute of Hematology and Transfusion Medicine


Most popular intervention types in "Institute of Hematology and Transfusion Medicine" are "Drug" (20 trials), "Biological" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "placebo" (3 trials), "FK463" (2 trials), "parsaclisib" (2 trials) and "ruxolitinib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Institute of Hematology and Transfusion Medicine


The vast majority of trials in "Institute of Hematology and Transfusion Medicine" are 23 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Institute of Hematology and Transfusion Medicine


Currently, there are NaN active trials in "Institute of Hematology and Transfusion Medicine". 1 are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Institute of Hematology and Transfusion Medicine, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Hematology and Transfusion Medicine, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 7Phase 2: 7Phase 1: 3Phase 1: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 14Completed: 14Active, not recruiting: 4Active, not recruiting: 4Recruiting: 2Recruiting: 2Unknown status: 2Unknown status: 2Not yet recruiting: 1Not yet recruiting: 1Terminated: 1Terminated: 1